DorzoComp-Vision SDU 20 mg/ml + 5mg/ml
DorzoComp-Vision SDU 20 mg/ml + 5mg/ml is a medicine authorised by Swissmedic under authorisation number 69149. The authorisation holder is OmniVision AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 08 June 2023 and the authorisation is limited until 07 June 2028. ATC code S01ED51 places the medicine in the group Ophthalmologicals.
| Authorisation number | 69149 |
|---|---|
| Name | DorzoComp-Vision SDU 20 mg/ml + 5mg/ml |
| Full name | DorzoComp-Vision SDU 20 mg/ml + 5mg/ml, Augentropfen |
| Authorisation holder | OmniVision AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | S01ED51 |
| First authorisation | 08 June 2023 |
| Authorisation validity | 07 June 2028 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | DorzoComp-Vision SDU 20 mg/ml + 5mg/ml, Augentropfen | B | 08 June 2023 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 60 x 0,2 ml | Einzeldose(n) | S01ED51 | 11.09.0. | B |
| 2 | 120 x 0,2 ml | Einzeldose(n) | S01ED51 | 11.09.0. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is DorzoComp-Vision SDU 20 mg/ml + 5mg/ml authorised in Switzerland?
Yes. DorzoComp-Vision SDU 20 mg/ml + 5mg/ml is authorised by Swissmedic under authorisation number 69149, data as of 01 September 2026. The authorisation is limited until 07 June 2028.
Which dispensing category does DorzoComp-Vision SDU 20 mg/ml + 5mg/ml have?
DorzoComp-Vision SDU 20 mg/ml + 5mg/ml is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of DorzoComp-Vision SDU 20 mg/ml + 5mg/ml?
The authorisation holder is OmniVision AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.